Saturday, November 15, 2025 11/15/2025

Instituting NCI-funded thyroid and head and neck cancer studies

Award Number: R50CA305244
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2025
PERIOD OF PERFORMANCE END DATE: 08/31/2030

Group Awards By:

View Award Description

Instituting NCI-funded thyroid and head and neck cancer studies - PROJECT SUMMARY/ABSTRACT Advancements in rare cancers can rarely be done outside of the National Cancer Institute (NCI) clinical trials network. Clinical studies for rare cancers need many institutions to participate and, due to their low incidence, are unlikely to be as profitable to the pharmaceutical industry as compared to advancements in treatment for more common cancers. Anaplastic thyroid cancers and oncocytic (formerly known as Hürthle cell) thyroid cancers are two prime examples of rare tumors with minimal prior research being done. Eric Sherman, MD, led and completed the first randomized studies conducted through the NCI clinical trials network that were focused on these cancers (RTOG-0912, A091302) as well as accrued the highest number of patients to both studies. Further support will help in these endeavors as Dr. Sherman focuses on developing future studies in rare cancers of the head and neck as well as supporting the success of both these and other studies of rare head and neck cancers both in the cooperative group setting (through both the Alliance in Clinical Trials for Oncology and NRG Oncology groups) and the Cancer Therapy Evaluation Program (CTEP; as part of the CTEP Anaplastic Thyroid Cancer Task Force and the NCI Head and Neck Rare Tumor Task Force). As part of his role at Memorial Sloan Kettering Cancer Center (MSK) as the Scientific Director of the Head and Neck Oncology Service and Co-Chair of the MSK Research Council, he will play a significant role in bringing NCI-supported studies to the institution and helping with their success.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $201,870 )
2025	2025	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Cancer Treatment Research	000	1	9/2/2025	NEW	$201,870
														Subtotal = $201,870

Grand Total All Awards = $201,870

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Instituting NCI-funded thyroid and head and neck cancer studies

Award Number: R50CA305244

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2025

PERIOD OF PERFORMANCE END DATE: 08/31/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer